205 related articles for article (PubMed ID: 33433063)
1. LncRNA SOX2-OT regulates AKT/ERK and SOX2/GLI-1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases.
Herrera-Solorio AM; Peralta-Arrieta I; Armas López L; Hernández-Cigala N; Mendoza Milla C; Ortiz Quintero B; Catalán Cárdenas R; Pineda Villegas P; Rodríguez Villanueva E; Trejo Iriarte CG; Zúñiga J; Arrieta O; Ávila-Moreno F
Mol Oncol; 2021 Apr; 15(4):1110-1129. PubMed ID: 33433063
[TBL] [Abstract][Full Text] [Related]
2. Failure to EGFR-TKI-based therapy and tumoural progression are promoted by MEOX2/GLI1-mediated epigenetic regulation of EGFR in the human lung cancer.
Peralta-Arrieta I; Trejo-Villegas OA; Armas-López L; Ceja-Rangel HA; Ordóñez-Luna MDC; Pineda-Villegas P; González-López MA; Ortiz-Quintero B; Mendoza-Milla C; Zatarain-Barrón ZL; Arrieta O; Zúñiga J; Ávila-Moreno F
Eur J Cancer; 2022 Jan; 160():189-205. PubMed ID: 34844838
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SOX2-OT regulates miR-192-5p/RAB2A axis and ERK pathway to promote glioblastoma cell growth.
Wang H; Hu Q; Tong Y; Li S; Chen M; Wang B; Li H
Cell Cycle; 2021 Oct; 20(19):2010-2020. PubMed ID: 34470582
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
5. IRF4-induced upregulation of lncRNA SOX2-OT promotes cell proliferation and metastasis in cholangiocarcinoma by regulating SOX2 and PI3K/AKT signaling.
Wei CX; Wong H; Xu F; Liu Z; Ran L; Jiang RD
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8169-8178. PubMed ID: 30556855
[TBL] [Abstract][Full Text] [Related]
6. The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer.
Jia Y; Gu D; Wan J; Yu B; Zhang X; Chiorean EG; Wang Y; Xie J
Oncogene; 2019 Mar; 38(10):1764-1777. PubMed ID: 30382189
[TBL] [Abstract][Full Text] [Related]
7. Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer.
Bora-Singhal N; Perumal D; Nguyen J; Chellappan S
Neoplasia; 2015 Jul; 17(7):538-51. PubMed ID: 26297432
[TBL] [Abstract][Full Text] [Related]
8. [SOX2-OT/SOX2 axis regulates lung cancer H520 cell migration
Dong H; Zeng L; Wu Y; Miao S; Ni N; Liu N; Chen W; DU J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1431-1439. PubMed ID: 36329576
[TBL] [Abstract][Full Text] [Related]
9. Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma.
Ooki A; Dinalankara W; Marchionni L; Tsay JJ; Goparaju C; Maleki Z; Rom WN; Pass HI; Hoque MO
Oncogene; 2018 Nov; 37(45):5967-5981. PubMed ID: 29980786
[TBL] [Abstract][Full Text] [Related]
10. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
11. Exosomal long non-coding RNA SOX2 overlapping transcript enhances the resistance to EGFR-TKIs in non-small cell lung cancer cell line H1975.
Zhou D; Xia Z; Xie M; Gao Y; Yu Q; He B
Hum Cell; 2021 Sep; 34(5):1478-1489. PubMed ID: 34244990
[TBL] [Abstract][Full Text] [Related]
12. The impact of LncRNA-SOX2-OT/let-7c-3p/SKP2 Axis on head and neck squamous cell carcinoma progression: Insights from bioinformatics analysis and experimental validation.
Wang D; Zhao X; Li S; Guo H; Li S; Yu D
Cell Signal; 2024 Mar; 115():111018. PubMed ID: 38110167
[TBL] [Abstract][Full Text] [Related]
13. Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway.
Wang L; Dong X; Ren Y; Luo J; Liu P; Su D; Yang X
Cell Death Dis; 2018 Jan; 9(2):129. PubMed ID: 29374157
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA SOX2-OT facilitates laryngeal squamous cell carcinoma development by epigenetically inhibiting PTEN via methyltransferase EZH2.
Tai Y; Ji Y; Liu F; Zang Y; Xu D; Ma S; Qin L; Ma J
IUBMB Life; 2019 Sep; 71(9):1230-1239. PubMed ID: 30811870
[TBL] [Abstract][Full Text] [Related]
15. LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers.
Chen C; Liu WR; Zhang B; Zhang LM; Li CG; Liu C; Zhang H; Huo YS; Ma YC; Tian PF; Qi Q; Li JJ; Tang Z; Zhang ZF; Giaccone G; Yue DS; Wang CL
Cancer Lett; 2020 Aug; 486():58-70. PubMed ID: 32439420
[TBL] [Abstract][Full Text] [Related]
16. Depression of long non-coding RNA SOX2 overlapping transcript attenuates lipopolysaccharide-induced injury in bronchial epithelial cells via miR-455-3p/phosphatase and tensin homolog axis and phosphatidylinositol 3-kinase/protein kinase B pathway.
Yi C; Gu T; Li Y; Zhang Q
Bioengineered; 2022 May; 13(5):13643-13653. PubMed ID: 35674016
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA SOX2-OT enhances cancer biological traits via sponging to tumor suppressor miR-122-3p and miR-194-5p in non-small cell lung carcinoma.
Dodangeh F; Sadeghi Z; Maleki P; Raheb J
Sci Rep; 2023 Jul; 13(1):12371. PubMed ID: 37524903
[TBL] [Abstract][Full Text] [Related]
18. Identification of an Exosomal Long Noncoding RNA SOX2-OT in Plasma as a Promising Biomarker for Lung Squamous Cell Carcinoma.
Teng Y; Kang H; Chu Y
Genet Test Mol Biomarkers; 2019 Apr; 23(4):235-240. PubMed ID: 30986097
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA SOX2-OT facilitates prostate cancer cell proliferation and migration via miR-369-3p/CFL2 axis.
Wo Q; Zhang D; Hu L; Lyu J; Xiang F; Zheng W; Shou J; Qi X
Biochem Biophys Res Commun; 2019 Dec; 520(3):586-593. PubMed ID: 31623830
[TBL] [Abstract][Full Text] [Related]
20. Exosome-mediated transfer of lncRNA RP11‑838N2.4 promotes erlotinib resistance in non-small cell lung cancer.
Zhang W; Cai X; Yu J; Lu X; Qian Q; Qian W
Int J Oncol; 2018 Aug; 53(2):527-538. PubMed ID: 29845246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
